
News|Articles|August 21, 2006
New product newswire: August 21, 2006
AstraZeneca, Wilmington, Del., (800) 842-9920, has received FDA approval for Symbicort (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol. The new inhaler is indicated for long-term maintenance treatment of asthma in patients 12 years of age and older.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA-Approved Sunscreen Filter Bemotrizinol Debuts in New US Products
2
Recombinant Shingles Vaccine May Lower Cardiovascular Risk
3
Updated Guideline Refines Approach to Migraine Prevention in Adults
4
Women, Men With Type 2 Diabetes Face Different Paths to Complications
5































